Skin care technology ventures into drugs delivery
has developed for skin care products in an attempt to break into
the drug delivery for cancer prevention treatments and gene repair
agents.
Cosmepure International has received a grant from a venture capital company that will be used to research the technology at the University of Nevada, Las Vegas, a project that is now at the preliminary stages of a year long study.
Cosmepure and its sister company CellMedics, in conjunction with chemist Dr Jacob Vromen, have developed a pantent-pending method that enables the delivery of drugs in the bloodstream using topical skin cream.
The claim is that the method is far more effective, less costly and ultimately of a greater benefit to patients.
The skin cream method, called transdermal-drug delivery, increases the effectiveness of drugs, lowers the dose required, and virtually eliminates side-effects," said Cosmepure chief executive Scott Shapiro.
"Cosmepure's researchers discovered the possibilities of administering drugs in skin cream after working on skin care products containing vitamins and micronutrients capable of deep penetration," he added.
According to a report from In Business Las Vegas, the research program will study skin cancer prevention and gene repair using vitamin C and vitamin B3 delivered in a skin cream form using the method developed by the company.
Many pharmaceutical companies have tried in the past to create skin creams for drug delivery but technical difficulties have made it too difficult to develop further, or else efficacy claims have been difficult to prove.
In the meantime Cosmepure is maintaining a division dedicated to the development of skin care products suitable for acne, anti-aging, psoriasis as well as repairing sun damaged skin, the report added.
